Sacroiliac Joint Pain
23
0
3
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 23 trials
100.0%
+13.5% vs benchmark
9%
2 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (23)
LINQ® Procedure vs. Conventional Medical Management for Sacroiliac Dysfunction
Innovative Spinopelvic Solutions With Real-World Evidence
Post-Market Clinical Study Using TRAQ™ for Minimally Invasive Posterior Sacroiliac Joint Fusion
Endoscopic and Cryoablation Denervation for Sacroiliac Joint Pain
Combination of Fluoroscopy and Ultrasonography Guidance in Sacroiliac Joint Injections. A Randomised Controlled Trial
iFuse TORQ for the Treatment of Sacroiliac Joint Dysfunction
CMCT Versus CSE in Treatment of SIJ Pain
Effects of KinesioTaping Versus Dry Needling in the Treatment of Sacroiliac Joint Pain Among Females.
Combined Corticosteroid Injections and Shockwave Therapy for Sacroiliac Joint Pain
Ketorolac Versus Corticosteroid Injections for Sacroiliac Joint Pain
Myofascial Release With and Without Support Belt for Sacroiliac Joint Pain in Pregnant Females.
High-intensity Laser Therapy for Sacroiliac Joint Pain
Efficacy of Adding LLL Therapy to Postural Correction Exercises on Postnatal SIJ Pain
Lateral Branch Cooled Radiofrequency Denervation vs. Conservative Therapy for Sacroiliac Joint Pain
Peripheral Nerve Stimulation for Treatment of Sacroiliac Joint Pain
Effect of Shockwave Versus LLL Therapy on Sacroiliac Joint Pain in Postnatal Women
Imaging for SIJ Injection Therapy
Making Better Lives: Patient-Focused Care for Low Back Pain (LBP)
Fluoroscopically-guided Versus Landmark-guided Sacroiliac Joint Injections
iFuse Implant System® Minimally Invasive Arthrodesis